| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Betty Y.S. Kim | Q73587185 |
| P2093 | author name string | James T Rutka | |
| Warren C W Chan | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanomedicine | Q261659 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 2434-2443 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Nanomedicine | |
| P478 | volume | 363 |
| Q43273036 | "One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics |
| Q47127845 | A Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal Therapy |
| Q36813889 | A Micro/Nano Composite for Combination Treatment of Melanoma Lung Metastasis |
| Q39119258 | A general approach to prepare conjugated polymer dot embedded silica nanoparticles with a SiO2@CP@SiO2 structure for targeted HER2-positive cellular imaging. |
| Q39140837 | Adamantane in Drug Delivery Systems and Surface Recognition. |
| Q57170723 | Advanced In-Vitro Cell Culture Methods Using Natural Biomaterials |
| Q38827304 | Advances and perspectives in tooth tissue engineering. |
| Q26830053 | All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease |
| Q28658189 | An emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnology |
| Q50449534 | An enzymatically-sensitized sequential and concentric energy transfer relay self-assembled around semiconductor quantum dots. |
| Q38755412 | An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology. |
| Q91940984 | Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner |
| Q38178222 | Anisotropic gold nanoparticles: synthesis, properties, applications, and toxicity |
| Q26828464 | Anti-HIV-1 nanotherapeutics: promises and challenges for the future |
| Q36780824 | Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens |
| Q35274033 | Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury |
| Q36312850 | Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG. |
| Q36786944 | Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1. |
| Q58698763 | Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells |
| Q58696083 | Application of Dendrimers for the Treatment of Infectious Diseases |
| Q37516225 | Application of nanotechnology to cancer radiotherapy |
| Q89497822 | Application of some nanoparticles in the field of veterinary medicine |
| Q64066446 | Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation |
| Q38477152 | Applications of nanoparticles for diagnosis and therapy of cancer |
| Q36608192 | Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes. |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q48661023 | Are they in or out? The elusive interaction between Qtracker ® 800 vascular labels and brain endothelial cells |
| Q64935260 | Assessment on interactive prospectives of nanoplastics with plasma proteins and the toxicological impacts of virgin, coronated and environmentally released-nanoplastics. |
| Q41587338 | Automatic reactor for solid-phase synthesis of molecularly imprinted polymeric nanoparticles (MIP NPs) in water. |
| Q26850547 | Bench-to-bedside translation of magnetic nanoparticles |
| Q36004218 | Binding of carbon nanotube to BMP receptor 2 enhances cell differentiation and inhibits apoptosis via regulating bHLH transcription factors |
| Q38501659 | Biodegradable chitosan nanoparticles in drug delivery for infectious disease |
| Q37003820 | Biodegradable micelles enhance the antiglioma activity of curcumin in vitro and in vivo |
| Q41344204 | Biodegradable polymeric micelle-encapsulated doxorubicin suppresses tumor metastasis by killing circulating tumor cells |
| Q38920722 | Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway |
| Q38391000 | Biomedical applications of gold nanomaterials: opportunities and challenges. |
| Q36472643 | Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties |
| Q90427212 | Breakthroughs in medicine and bioimaging with up-conversion nanoparticles |
| Q28396571 | Building an ethical foundation for first-in-human nanotrials |
| Q38091386 | CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products |
| Q34447986 | Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. |
| Q45811171 | Carrier-free nanoassemblies of a novel oxazolidinone compound FYL-67 display antimicrobial activity on methicillin-resistant Staphylococcus aureus |
| Q35547044 | Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: lipid nanoparticles versus polymeric nanoparticles |
| Q38303401 | Cationic carbosilane dendrimers and oligonucleotide binding: an energetic affair |
| Q56996635 | Ceria nanoparticles with rhodamine B as a powerful theranostic agent against intracellular oxidative stress |
| Q91233954 | Cerulein-induced chronic pancreatitis in Swiss albino mice: An improved short-term model for pharmacological screening |
| Q90288764 | Challenges in nanomedicine clinical translation |
| Q33651804 | Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging |
| Q39147958 | Colloidal capsules: nano- and microcapsules with colloidal particle shells. |
| Q42129565 | Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform |
| Q57358066 | Cooperativity Principles in Self-Assembled Nanomedicine |
| Q38252642 | Core-shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery. |
| Q28383550 | Cytokines as biomarkers of nanoparticle immunotoxicity |
| Q39249056 | Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma |
| Q58614386 | Defragmentation of lysozyme derived Amyloid β fibril using Biocompatible Magnetic fluid |
| Q38296086 | Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation. |
| Q38270094 | Designing a better theranostic nanocarrier for cancer applications |
| Q88352795 | Detecting the functional complexities between high-density lipoprotein mimetics |
| Q38608740 | Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches |
| Q42176425 | Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells |
| Q39000589 | Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies. |
| Q38718577 | Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines |
| Q37728142 | Diverse Applications of Nanomedicine |
| Q90332778 | Drug-Triggered Self-Assembly of Linear Polymer into Nanoparticles for Simultaneous Delivery of Hydrophobic and Hydrophilic Drugs in Breast Cancer Cells |
| Q36899044 | Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates |
| Q37029367 | Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? |
| Q37613438 | Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity |
| Q37225620 | Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line |
| Q64272058 | Emerging Nano-/Microapproaches for Cancer Immunotherapy |
| Q38027231 | Emerging role of radiolabeled nanoparticles as an effective diagnostic technique |
| Q35972532 | Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention |
| Q46633708 | Engineered porphyrin loaded core-shell nanoparticles for selective sonodynamic anticancer treatment |
| Q38056410 | Engineering imaging probes and molecular machines for nanomedicine |
| Q30434707 | Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound |
| Q46489524 | Enhanced selective sonosensitizing efficacy of ultrasound-based anticancer treatment by targeted gold nanoparticles |
| Q39379323 | Ethnopharmacological uses, phytochemistry, biological activities, and biotechnological applications of Eclipta prostrata |
| Q36088770 | Exploiting Size-Dependent Drag and Magnetic Forces for Size-Specific Separation of Magnetic Nanoparticles |
| Q30847182 | Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect |
| Q55461327 | Facile synthesis of ultra-small hybrid silica spheres for enhanced penetration in 3D glioma spheroids. |
| Q37238658 | Feasibility of Energy Dispersive X-Ray Fluorescence Determination of Gold in Soft Tissue for Clinical Applications |
| Q92023900 | Focused Ultrasonography-Mediated Blood-Brain Barrier Disruption in the Enhancement of Delivery of Brain Tumor Therapies |
| Q30434475 | Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology |
| Q28597202 | Formation and characteristics of biomimetic mineralo-organic particles in natural surface water |
| Q41834840 | Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues |
| Q88981438 | From Nanowarming to Thermoregulation: New Multiscale Applications of Bioheat Transfer |
| Q92990832 | Functional Protein-Based Bioinspired Nanomaterials: From Coupled Proteins, Synthetic Approaches, Nanostructures to Applications |
| Q42379631 | Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain |
| Q57786817 | Gold nanoparticles enhance X-ray irradiation-induced apoptosis in head and neck squamous cell carcinoma |
| Q34584366 | Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications |
| Q93377755 | Gold nanorods/siRNA complex administration for knockdown of PARP-1: a potential treatment for perinatal asphyxia |
| Q37682675 | Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types. |
| Q35859834 | Green Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia prostrata Extract Shows Shift from Apoptosis to G0/G1 Arrest followed by Necrotic Cell Death in Leishmania donovani |
| Q90310328 | Gut microbiota and cardiovascular disease: opportunities and challenges |
| Q90445348 | High Z nanoparticles and radiotherapy: a critical view |
| Q35264780 | High content analysis provides mechanistic insights on the pathways of toxicity induced by amine-modified polystyrene nanoparticles |
| Q51082429 | High-Throughput Fabrication of Nanocomplexes Using 3D-Printed Micromixers. |
| Q36777228 | High-sensitivity nanosensors for biomarker detection |
| Q39037527 | Horizon scan of nanomedicinal products. |
| Q38193109 | How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations |
| Q58581087 | Image-Guided Cancer Nanomedicine |
| Q38039974 | Immune response to nanomaterials: implications for medicine and literature review |
| Q41597466 | Improved tissue cryopreservation using inductive heating of magnetic nanoparticles. |
| Q51075805 | Improvement in Spinal Cord Injury-Induced Bladder Fibrosis Using Mesenchymal Stem Cell Transplantation Into the Bladder Wall. |
| Q39293603 | Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma |
| Q36848111 | Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming |
| Q35687164 | Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles |
| Q38405765 | In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles |
| Q24595399 | In vivo bio-imaging using chlorotoxin-based conjugates |
| Q37602017 | Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation |
| Q34127625 | Insight into nanoparticle cellular uptake and intracellular targeting |
| Q38074442 | Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy |
| Q28391849 | Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine |
| Q36786227 | Intratracheal Administration of Prostacyclin Analogue-incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension. |
| Q64076280 | Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives |
| Q91905865 | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| Q30467283 | Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization |
| Q41830647 | Local immunomodulation for cancer therapy: Providing treatment where needed |
| Q37955034 | Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. |
| Q36574654 | Managing diabetes with nanomedicine: challenges and opportunities |
| Q37462904 | Mechanism of hard-nanomaterial clearance by the liver. |
| Q57559237 | Medical Applications of Iron Oxide Nanoparticles |
| Q37234102 | Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids. |
| Q37895950 | Mesoporous silica nanoparticles as nanocarriers. |
| Q34435740 | Microfluidic technologies for accelerating the clinical translation of nanoparticles |
| Q37358577 | Microvascular targets for anti-fibrotic therapeutics |
| Q37467770 | Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. |
| Q52584537 | Modular assembly of proteins on nanoparticles. |
| Q35388723 | Molecular imaging with theranostic nanoparticles |
| Q98895825 | Morphological and Semi-empirical Study of the Pluronic F68/Imogolite/Sudan III Intersurfaces Composite for the Controlled Temperature Release of Hydrophobic Drugs |
| Q39693429 | Multi-analyte suspension arrays for the detection of common viruses: how viable are these assays in clinical laboratories? |
| Q26865418 | Multifunctional nanoparticles for brain tumor imaging and therapy |
| Q38103964 | Multifunctional nanoparticles for drug delivery and molecular imaging |
| Q36545276 | Multimodal iron oxide nanoparticles for hybrid biomedical imaging |
| Q38124738 | Multiple strategies to activate gold nanoparticles as antibiotics |
| Q28078448 | NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? |
| Q38095868 | Nano-sized CT contrast agents. |
| Q38064922 | Nanodentistry: combining nanostructured materials and stem cells for dental tissue regeneration |
| Q38495085 | Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions. |
| Q38529529 | Nanofibers used for the delivery of analgesics |
| Q37473193 | Nanoformulation of natural products for prevention and therapy of prostate cancer |
| Q28387114 | Nanoinformatics: a new area of research in nanomedicine |
| Q28728194 | Nanoinformatics: developing new computing applications for nanomedicine |
| Q27008517 | Nanoinformatics: emerging databases and available tools |
| Q35019550 | Nanomedical engineering: shaping future nanomedicines |
| Q41545896 | Nanomedicinal products: a survey on specific toxicity and side effects |
| Q27022253 | Nanomedicine approaches for corneal diseases |
| Q26775137 | Nanomedicine concepts in the general medical curriculum: initiating a discussion |
| Q92982680 | Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome |
| Q95936527 | Nanomedicine-based immunotherapy for central nervous system disorders |
| Q57168448 | Nanomedicine: Principles, Properties, and Regulatory Issues |
| Q35558902 | Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer |
| Q37656497 | Nanomedicine: tiny particles and machines give huge gains |
| Q30387307 | Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. |
| Q35553193 | Nanoparticle PEGylation for imaging and therapy |
| Q43952374 | Nanoparticle accumulation in angiogenic tissues: towards predictable pharmacokinetics. |
| Q26863316 | Nanoparticle contrast agents for computed tomography: a focus on micelles |
| Q26866082 | Nanoparticle delivery enhancement with acoustically activated microbubbles |
| Q37104463 | Nanoparticle mediated non-covalent drug delivery |
| Q33737242 | Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension |
| Q64990898 | Nanoparticle-based bioactive agent release systems for bone and cartilage tissue engineering. |
| Q30354652 | Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer. |
| Q38136246 | Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q35334027 | Nanoporous silica-based protocells at multiple scales for designs of life and nanomedicine |
| Q45367836 | Nanosafety: towards safer design of nanomedicines |
| Q28389760 | Nanoscale bacteriophage biosensors beyond phage display |
| Q36794937 | Nanoscale materials for hyperthermal theranostics |
| Q58324579 | Nanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media |
| Q64903555 | Nanotechnology Inclusion in Pharmaceutical Sciences Education in Portugal. |
| Q64956054 | Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. |
| Q38595840 | Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier |
| Q34124280 | Nanotechnology in radiation oncology. |
| Q48155889 | Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed |
| Q38748343 | Near-infrared biophotonics-based nanodrug release systems and their potential application for neuro-disorders |
| Q40536041 | New, rapid method to measure dissolved silver concentration in silver nanoparticle suspensions by aggregation combined with centrifugation |
| Q57287856 | Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma |
| Q48243936 | Nitric Oxide Dependent Degradation of Polyethylene Glycol-Modified Single-Walled Carbon Nanotubes: Implications for Intra-Articular Delivery |
| Q94594710 | Nitroxide Radical-Containing Redox Nanoparticles Protect Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine Toxicity |
| Q37131939 | Nonporous Silica Nanoparticles for Nanomedicine Application. |
| Q37515614 | Novel antimicrobial peptide-modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus |
| Q38148787 | Novel approaches in antimalarial drug discovery |
| Q46876149 | On the use of dexamethasone-loaded liposomes to induce the osteogenic differentiation of human mesenchymal stem cells |
| Q38025039 | Orchestrating cell/material interactions for tissue engineering of surgical implants |
| Q91905843 | Oxidized carbon nanoparticles as an effective protein antigen delivery system targeting the cell-mediated immune response |
| Q34062299 | P-glycoprotein-dependent trafficking of nanoparticle-drug conjugates |
| Q86070052 | PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic |
| Q34982384 | PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway |
| Q48245916 | Particle generation, functionalization and sortase A-mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use. |
| Q33444490 | Pediatric Pathology In The Year 2050. |
| Q37869417 | Pediatric oncology and the future of oncological imaging |
| Q83747099 | Peptide nanomedicines for treatment of acute lung injury |
| Q30455490 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. |
| Q38563324 | Physical Principles of Nanoparticle Cellular Endocytosis. |
| Q38105872 | Plasmonic nanoprobes for intracellular sensing and imaging. |
| Q38156233 | Poly(amidoamine) dendrimer complexes as a platform for gene delivery. |
| Q64107133 | Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems |
| Q39117499 | Polyphenols delivery by polymeric materials: challenges in cancer treatment. |
| Q27025494 | Polysaccharide nanosystems for future progress in cardiovascular pathologies |
| Q30898107 | Potential dual imaging nanoparticle: Gd2O3 nanoparticle. |
| Q38193126 | Potential environmental implications of nano-enabled medical applications: critical review |
| Q27692708 | Prevention and treatment of biofilms by hybrid- and nanotechnologies. |
| Q48323722 | Prudent precaution in clinical trials of nanomedicines |
| Q38900922 | Quantifying the cellular uptake of semiconductor quantum dot nanoparticles by analytical electron microscopy |
| Q91794022 | Quantitative Analysis of Different Cell Entry Routes of Actively Targeted Nanomedicines Using Imaging Flow Cytometry |
| Q54087835 | Quantitative characterization of nanoparticle agglomeration within biological media |
| Q53034248 | RGD-QD-MoS2 nanosheets for targeted fluorescent imaging and photothermal therapy of cancer. |
| Q92442221 | Radiolabeled PET/MRI Nanoparticles for Tumor Imaging |
| Q38997208 | Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer |
| Q35204179 | Rapid determination of plasmonic nanoparticle agglomeration status in blood. |
| Q26865564 | Reactive oxygen species-activated nanomaterials as theranostic agents |
| Q46938274 | Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries |
| Q47251361 | Recent Advances in Managing Atherosclerosis via Nanomedicine. |
| Q61456277 | Recent Development of pH-Responsive Polymers for Cancer Nanomedicine |
| Q38098301 | Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. |
| Q38093094 | Recent progress in nanosensors for sensitive detection of biomolecules |
| Q57352274 | Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion |
| Q27308007 | Recovery of Cognitive Dysfunction via Orally Administered Redox-Polymer Nanotherapeutics in SAMP8 Mice |
| Q89968137 | Redox-Responsive Dipeptide Nanostructures toward Targeted Cancer Therapy |
| Q57377525 | Responsive crosslinked polymer nanogels for imaging and therapeutics delivery |
| Q38537318 | Resveratrol nanoformulation for cancer prevention and therapy |
| Q30410029 | Rethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories |
| Q36088140 | Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform |
| Q36659125 | Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles |
| Q46210517 | Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks. |
| Q36390455 | Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. |
| Q39991731 | Shining light on nuclear-targeted therapy using gold nanostar constructs |
| Q35051151 | Silicone Membranes to Inhibit Water Uptake into Thermoset Polyurethane Shape-Memory Polymer Conductive Composites |
| Q34613544 | Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip |
| Q38353285 | Single-walled carbon nanotubes as near-infrared optical biosensors for life sciences and biomedicine |
| Q34290392 | Size matters: gold nanoparticles in targeted cancer drug delivery |
| Q82152547 | Skin-like pressure and strain sensors based on transparent elastic films of carbon nanotubes |
| Q34331704 | Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells |
| Q37638621 | Smart Mesoporous Nanomaterials for Antitumor Therapy. |
| Q40051164 | State of diagnosing infectious pathogens using colloidal nanomaterials |
| Q51826960 | Suppression of the reticuloendothelial system using λ-carrageenan to prolong the circulation of gold nanoparticles. |
| Q31056225 | Synthesis, characterization, DNA binding, cleavage activity, cytotoxicity and molecular docking of new nano water-soluble [M(5-CH₂PPh₃-3,4-salpyr)](ClO₄)₂ (M = Ni, Zn) complexes. |
| Q37850337 | Synthetic pathways to make nanoparticles fluorescent |
| Q38987405 | Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy |
| Q27023361 | Targeted therapy using nanotechnology: focus on cancer |
| Q27009549 | Techniques for physicochemical characterization of nanomaterials |
| Q64119756 | The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses |
| Q38784932 | The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction |
| Q39527453 | The nanomedicine revolution: part 2: current and future clinical applications. |
| Q36401768 | The nanomedicine revolution: part 3: regulatory and safety challenges |
| Q30375791 | The role of philosophy of science in Responsible Research and Innovation (RRI): the case of nanomedicine. |
| Q55543316 | The toxicity and therapeutic effects of single-and multi-wall carbon nanotubes on mice breast cancer. |
| Q39008913 | Three-layered polyplex micelle as a multifunctional nanocarrier platform for light-induced systemic gene transfer |
| Q38759409 | Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in vitro and in vivo. |
| Q35201507 | Treating cancer stem cells and cancer metastasis using glucose-coated gold nanoparticles |
| Q30369255 | Trimodal Therapy: Combining Hyperthermia with Repurposed Bexarotene and Ultrasound for Treating Liver Cancer. |
| Q52726131 | Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence. |
| Q26785347 | Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting |
| Q37937424 | Unravelling the complexity of metastasis - molecular understanding and targeted therapies |
| Q37451733 | Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy |
| Q57079916 | Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions |
| Q37900930 | Use of thin sectioning (nanoskiving) to fabricate nanostructures for electronic and optical applications |
| Q36265239 | Visible-light-responsive ZnCuO nanoparticles: benign photodynamic killers of infectious protozoans |
| Q33774391 | XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles |
| Q37449500 | pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma |
| Q46305754 | pH-sensitive metal-phenolic network capsules for targeted photodynamic therapy against cancer cells |
| Q38941700 | qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development. |
Search more.